Stay updated on Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial page.

Latest updates to the Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedNo text changes (additions or deletions) are present in the provided data.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision v3.5.4 was added to the record history and Revision v3.5.3 was removed, updating the study's version history.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe record history now includes a later submitted version (dated 2026-03-27) showing the study status change and additional sections populated/available such as participant flow, baseline characteristics, outcome measures (results), and adverse events. It also shows that the results were returned on 2026-04-16 with “Quality Control Review Has Not Concluded,” meaning the trial’s results have progressed to a new stage of the record lifecycle.SummaryDifference1%

- Check43 days agoChange DetectedAdded revision v3.5.2 and removed revision v3.5.0 from the record history.SummaryDifference0.1%

- Check58 days agoChange DetectedRecord history adds 'Results Submitted' as a new status, replacing the previous 'No Results Posted'.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the record history.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial page.